Although the expression of the MYC protein is stimulated by estrogen and downregulated by tamoxifen in hormone-responsive breast tumors in vitro [51-54], we found that MYC amplification was correlated with the absence of estrogen receptor, which is in agreement with other studies [21,55] but contradictory to others [56,57]. Here, ESR1 is linked to breast neoplasm.